Like PO3, these large investors paying premium and buying their board seat are usually a sign that there is plenty upside to follow. I see from PBT's website that they are leveraging the anti-aging market to the max.
Believe in it or not, it is very big business. But on that note, the 'quality of ageing life' is a more appropriate description. I note there work in epigenetics. This is where AIY has also entered with their buying into Aenea.
Short Term Trading New Year: 27 Dec - 1 Jan, page-109
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add XAO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8,705.0 |
Change
5.900(0.07%) |
Mkt cap ! n/a | |||
| Open | High | Low |
| 8,699.1 | 8,727.7 | 8,694.0 |
| XAO (ASX) Chart |
